Published On: Вс, Сен 16th, 2018

Cancer drug victory as thousands benefit

THOUSANDS of lung cancer patients will have access to potentially life-saving immunotherapy cancer drugs, following a ruling by European health chiefs. The announcement, made last week by the European Commission, was prompted by a trial which showed that over two years patients with advanced lung cancer were 51 per cent more likely to survive with immune-boosting drugs than by standard treatment – at least doubling their 12-month life expectancy.
Daily Express :: Health Feed

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>